| || ||     |
Advanced Imaging for Glaucoma
Casey Eye Institute, OHSU
3375 Southwest Terwilliger Boulevard
Portland, OR 97239-4197
Welcome to the AIG Study Website
Advanced Imaging for Glaucoma (AIG) is a multi-center bioengineering partnership sponsored by the National Eye Institute, one of the National Institutes of Health (NIH).
The goal of this partnership is to develop advanced imaging technologies that can improve the detection and management of glaucoma. Currently-employed advanced imaging devices include optical coherence tomography, scanning laser polarimetry and scanning laser tomography. The imaging technologies will be evaluated in a longitudinal 5-year clinical trial. The study subjects will include patients with normal eyes, patients with glaucoma, and individuals at risk for developing glaucoma.
September 2012 - CONGRATULATIONS to David Huang and Joel S. Schuman
David Huang and Joel S. Schuman, AIGS co-investigators, along with colleagues are the recipients of the 2012 Champalimaud Vision Award. The most prestigious award in vision, often called the "Nobel Prize for Vision" was presented to the winners in Lisbon, Portugal, by the President of Portugal, Aníbal António Cavaco Silva.
Please see the following links for more information:
July 7, 2011
The coordinating center for the AIG partnership is located at the Oregon Health & Science Unversity (OHSU). There are a total of four centers that will be conducting the AIG clinical study, two basic science and engineering centers that will develop the advanced imaging instruments and conduct laboratory studies on glaucoma and one resource center.
Basic science and engineering centers:
The specific aims of the AIG clinical studies are to:
1. Predict the development of visual field (VF) abnormalities in individuals at risk for developing glaucoma based on anatomic abnormalities detected by advanced imaging;
2. Predict the development of VF abnormalities in individuals at risk for developing glaucoma based on anatomic changes detected between successive advanced imaging tests; and
3. Determine the sensitivity and specificity of a glaucoma diagnosis based on advanced imaging tests.
|Copyright 2005 AIG Study. All rights reserved.|